Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Heterogeneous Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106565620A reveals a novel gamma-Fe2O3 catalyst for tetrazole synthesis, offering high purity, cost reduction, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN104974088B reveals WO3/TiO2 catalyzed oxidation. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN101429082A reveals a silica-catalyzed route for alpha-chloro ketones using dichlorohydantoin. Achieve high purity, reduced waste, and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN105037274B enables continuous benzimidazole production. High yield, reduced waste, reliable supply chain for pharmaceutical intermediates.
Advanced synthesis of entecavir intermediate via novel iron-catalyzed Friedel-Crafts alkylation. Offers superior purity, cost efficiency, and scalable supply chain solutions.
Novel silica-supported catalytic route for benzothiazole derivatives ensures high purity and simplified post-treatment for reliable pharmaceutical intermediate supply chains.
Patent CN103467306A reveals a safer hydrotalcite-catalyzed route for iodoaniline derivatives, offering superior yield and supply chain stability for pharmaceutical intermediates.
Patent CN112174970B reveals a scalable method for Pemetrexed Disodium using alkali-modified molecular sieves, ensuring high yield and reduced environmental impact.
Patent CN102603546B reveals a green synthesis route for N-substituted-3-aminoacrolein using air oxidation, offering significant cost reduction and supply chain safety for pharma intermediates.
Patent CN112142686B details a green heterogeneous catalytic method for benzothiazoles using HKUST-1 derivatives, offering high purity and recyclability for pharma intermediates.
Patent CN101613263B details a novel MnO2 oxidation route for carvone. Achieve >99% purity with simplified workflow and reduced environmental impact for flavor industries.
Patent CN103951549B offers high-yield celecoxib intermediate synthesis. Reduces waste and cost for pharmaceutical intermediates manufacturing supply chains.
Novel one-step catalytic method for 5-p-hydroxyphenylhydantoin production. Reduces waste, improves yield, ensures supply chain stability for global pharmaceutical intermediates.
Patent CN114656494B reveals a novel chitosan copper catalyst for allyl borate synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN109608401A reveals chitosan-copper catalysis for diarylamines. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes.
Patent CN101805307B reveals a magnetic nano-catalytic route for tetrazole synthesis, offering high purity, easy separation, and significant cost reduction for pharmaceutical supply chains.
Patent CN110540540B details a magnetic nano-catalyzed route for dihydro[1,2,4]triazolo[1,5-a]pyrimidines. Discover cost-effective, scalable manufacturing solutions.
Patent CN113061091B reveals a green Cu-Co/Al2O3 catalytic route for N-alkylation. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN109096148B reveals a novel one-pot method for Vorinostat using modified mesoporous silica, offering high purity and simplified supply chain for pharmaceutical manufacturers.
Patent CN108689952B reveals a heterogeneous oxidation method for prothioconazole using aromatic solvents, enabling significant cost reduction and simplified purification for agrochemical manufacturers.